Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors
Titel:
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors
Auteur:
Papadopoulos, Kyriakos P. Lakhani, Nehal Falchook, Gerald S. Riley, Gosia Baeck, Johan Brown, Karen S. Gordon, Gilad Le, Lidya Wang, Judy S.